A curated list of prominent family offices actively deploying capital into early-stage artificial intelligence companies within the healthcare sector. These entities leverage their long-term investment horizons and specialized networks to support innovative startups in medical imaging, drug discovery, and personalized medicine.
Get targeted exposure with custom position pinning and highlighted placement.
A global charitable foundation with significant impact investing arms dedicated to solving major health challenges. It actively supports innovative health technology ventures, including those leveraging AI for diagnostics and treatment, by providing both funding and strategic operational support to accelerate scientific breakthroughs.
Founded by Mark Zuckerberg and Priscilla Chan, this entity focuses on advancing human potential and promoting equality. It invests in data-driven health initiatives and AI tools aimed at improving education and healthcare outcomes, particularly in underserved communities through targeted tech development.
While technically a VC firm, it is heavily backed by family office capital and maintains a strong presence in healthtech. They are known for early-stage investments in AI-driven healthcare solutions, providing deep industry expertise and extensive network access to startups in digital health and biotech.
A private investment firm owned by the Johnson family, offering significant capital to early-stage private markets. Their healthcare group actively seeks AI healthtech opportunities, combining traditional healthcare insights with modern data science investments to identify transformative medical technologies.
A multi-generational family office focused on healthcare innovation and technology. They invest in companies that are reshaping patient care through digital platforms, AI analytics, and telehealth services, prioritizing ventures that demonstrate scalable impact on healthcare efficiency and patient outcomes.
Associated with the Chan Zuckerberg and Didi Hui funds, this foundation supports scientific advancement. While primarily a prize entity, it facilitates investments and partnerships in cutting-edge research, including AI applications in genomics and disease modeling, fostering an ecosystem for healthtech innovation.
A pioneering venture capital firm with significant family office backing, historically known for its healthcare investments. They actively pursue AI healthtech startups, offering capital and strategic guidance to companies developing novel algorithms for medical diagnostics, clinical trial optimization, and personalized therapy.
A leading global venture capital firm heavily supported by family office capital. Their health team invests in AI-powered healthtech companies, focusing on building foundational technologies that enhance diagnostic accuracy, streamline clinical workflows, and improve overall healthcare delivery systems.
A prominent venture capital firm with strong family office ties, actively investing in healthtech. They support AI startups through dedicated bio-health teams that provide resources for regulatory navigation and market entry, helping companies scale innovative solutions in medical AI and digital therapeutics.
The venture capital arm of Alphabet, supported by family-like strategic capital. GV invests heavily in AI healthtech, providing data resources and technical expertise to startups developing AI for drug discovery, medical imaging, and health data analytics, accelerating the commercialization of AI in medicine.
The corporate venture arm of the Johnson family-controlled company, investing in early-stage healthtech. They focus on AI-driven solutions in medtech, pharma, and digital health, offering startups not only capital but also access to global regulatory networks and commercialization pathways.
Invests in early-stage biotech and digital health companies, including those using AI. Backed by the Roche family legacy, it supports ventures developing AI tools for diagnostics and personalized medicine, leveraging global healthcare infrastructure to help startups scale and reach patients faster.
The commercial investment arm of the Novo Nordisk Foundation, managed by the Novo Nordisk family. They invest in digital health and AI-driven healthcare solutions, aiming to improve patient care and reduce costs through innovative technologies that enhance efficiency and outcomes in healthcare systems.
The investment arm of Pfizer, supporting early-stage biotech and digital health. They focus on AI applications in drug discovery and development, partnering with startups to accelerate the creation of new therapies and improve clinical trial efficiency through advanced data analytics and machine learning.
While primarily focused on deep tech, it has interests in AI health applications. Supported by institutional and family-like capital, it invests in foundational technologies that can be adapted for healthtech, including AI algorithms for complex data analysis applicable to medical research and diagnostics.
A leading venture capital and private equity firm with significant family office investor base. They invest in AI healthtech companies, providing growth capital and operational support to scale digital health platforms, focusing on companies with strong product-market fit and scalable AI models.
A European healthcare-focused growth equity firm, supported by family office capital. They invest in AI healthtech companies across the lifecycle, providing strategic support to companies developing AI solutions for diagnostics, treatment, and healthcare management, particularly in the European market.
A venture capital firm focused on transforming science into life-saving medicines, with family office backing. They invest in AI-driven drug discovery platforms, supporting startups that use computational biology and machine learning to identify novel therapeutic targets and accelerate drug development pipelines.
A venture studio that creates and invests in transformative health companies, supported by significant capital. They develop AI healthtech ventures from the ground up, leveraging deep scientific expertise and data science to solve major unmet medical needs, often incubating startups within their portfolio.
A startup accelerator with a significant healthtech track record, supported by diverse investor base including family offices. They invest in early-stage AI healthtech companies, providing seed funding and intensive mentorship to help founders validate their AI models and navigate healthcare regulatory landscapes.